Navigation Links
Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of the American Society of Clinical Oncology has published the early results of a clinical study conducted by Dr. Siu-Fun Wong, and her colleagues, which concluded that the topical gel, Regenecare(R), caused a statistically significant reduction in the pain and itching of a rash that results from the use of anti-cancer drugs known as EGFR inhibitors. This ongoing supportive care trial is listed on the National Cancer Institute Clinical Trials website (www.cancer.gov).

Paul Miller, President of MPM Medical, stated, "EGFR inhibitors form a group of drugs, sold by several pharmaceutical companies, which are effective in the treatment of cancer. However, after a few weeks of use, an acne-like rash often appears on the face, neck, back, hands, and/or legs resulting in severe pain and itching for the patient. We know of no other evidence-based topical applications reported in the scientific literature shown to help manage rash symptoms caused by EGFR drugs."

Regenecare(R) is a proprietary product of MPM Medical, Inc., a wholly owned subsidiary of RBC Life Sciences, Inc. (OTCBB:RBCL).

MPM Medical develops and markets a line of prescription and nonprescription products for wound management, through medical-surgical dealers, to nursing homes, hospitals, and cancer clinics.

The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

Contact

RBC Life Sciences, Inc.
Steve Brown, CFO, 972-893 4000
steveb@rbcls.com
www.mpmmedicalinc.com


'"/>




Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2018)... ... September 01, 2018 , ... Dr. Payam Bostani is now offering Periodontal Osseous ... has been offering patients for twenty years at his Burbank offices. “My goal ... likely to need under a single roof. Periodontics is a crucial specialty because our ...
(Date:8/31/2018)... ... August 31, 2018 , ... Power Systems, a leading provider of ... brand, have partnered in a shared mission to motivate 100 million people to get ... on the rise since 2010, offering competitors a fun and complete physical challenge. Spartan ...
(Date:8/31/2018)... ... August 31, 2018 , ... The Centers for Disease ... years of expertise in delivering comprehensive wellness engagement solutions, has been selected as ... Health will receive a $40,000 grand prize for its winning proposal, Closing the ...
Breaking Medicine Technology:
(Date:9/12/2018)... ... , ... Glori Blends will be attending the CBD Expo West 2018 in ... vendors, presentations, panel discussions and a special pavilion for pet line products. The creators ... and assist customers with the best selection for their individual needs. , The address ...
(Date:9/7/2018)... ... September 07, 2018 , ... Start your engines and race to the ... from which to choose. Pedal power is the name of the game here – ... turning left on the miniature Indianapolis Motor Speedway oval. , The timing couldn’t be ...
(Date:9/7/2018)... ... September 07, 2018 , ... The Ramsey Keller Memorial ... first-ever national retreat for moms who are living without a child. “ The Retreat ... of October 26, 27 and 28 at Fairmont Hot Springs Resort near ...
(Date:9/2/2018)... ... September 01, 2018 , ... ... MD® Elite to its leading menu of results-driven aesthetic treatments. HydraFacial is ... infusion of clinically-proven ingredients to dramatically improve your skin’s tone and texture ...
(Date:9/1/2018)... (PRWEB) , ... August 31, 2018 , ... “Vitamin D ... CEO of Trivedi Effect, debuted as a hot new release in Vitamins and Supplements, ... Seller. She is currently on a media tour around the United States. , With ...
Breaking Medicine News(10 mins):